Logo image of SUPN

SUPERNUS PHARMACEUTICALS INC (SUPN) Stock Analyst Ratings

NASDAQ:SUPN - Nasdaq - US8684591089 - Common Stock - Currency: USD

32.1  +0.06 (+0.19%)

After market: 32.1 0 (0%)

Buy % Consensus

78

ChartMill assigns a Buy % Consensus number of 78% to SUPN. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 39.58. This target is 23.29% above the current price.
SUPN was analyzed by 11 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about SUPN.
In the previous month the buy percentage consensus was at a similar level.
SUPN was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.

Related screens

SUPN Historical Analyst RatingsSUPN Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -101 -92 -83 -74 -65 -56 -47 -38 -29 -20 -11 -2 5 10 15

Price Target & Forecast

Price Low Median Mean High 32.1036.3638.7639.5846.20 - 13.27% 20.75% 23.29% 43.93%

Related screens

SUPN Current Analyst RatingSUPN Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2025-02-26 Cantor Fitzgerald Reiterate Neutral -> Neutral
2025-02-19 Cantor Fitzgerald Downgrade Overweight -> Neutral
2024-09-11 Piper Sandler Downgrade Overweight -> Neutral
2024-02-28 Piper Sandler Maintains Overweight -> Overweight
2023-11-09 Piper Sandler Maintains Overweight -> Overweight
2023-10-25 Piper Sandler Maintains Overweight -> Overweight
2023-05-10 Piper Sandler Maintains Overweight -> Overweight
2023-01-23 Piper Sandler Maintains Overweight
2022-08-31 Piper Sandler Maintains Overweight
2021-04-13 Jefferies Upgrade Hold -> Buy